Effective Vaccinations can lead to Decrease in Antibiotic Use by:

  • Reducing incidence of bacterial infections
  • Reducing the fear of serious infectious complications
  • Reducing the incidence of viral infections that are frequently mistreated with antibiotics

Antibiotic Use has Decreased Since Introduction of Pneumococcal Vaccination

  • In the United States, rates of antibiotic prescribing to children have declined since the 1990s; since that time period, PCV7 was introduced in 2000 and replaced by PCV13 in 2010, and several national treatment guidelines for common pediatric infections were published during that time period as well.
  • A Danish study on national antibiotic prescribing found the proportion of infants prescribed at least one antibiotic prescription decreased from 40.7% among infants born in 2004 to 34.6% among infants born in 2012; during this time, 2 pneumococcal conjugate vaccines (PCVs) (PCV7 in 2007 and PCV13 in 2010) were introduced along with national antibiotic prescribing guidelines in 2007. (Kinlaw A, Sturmer T, Lund J, et al. Trends in antibiotic use by birth season and birth year. Pediatrics. 2017; 140(3):e20170441)

Antibiotic Resistance has Decreased Since Introduction of Pneumococcal Vaccinations

PCV7

PCV13

Vaccinations Decrease the Incidence of Serious Bacterial Infections

Global Impact

  • The Center for Disease Dynamics, Economics & Policy estimates that universal coverage of children under 5 years with a pneumococcal conjugate vaccine in the 75 countries in their analysis could avert up to 11.4 million days of antibiotics per year. (Laxminarayan, R et al. Access to effective Antibiotics: a worldwide challenge. The Lancet, Volume 387, Issue 10014, 168 – 175)

Cocooning Protects Vulnerable Populations, Specifically Our Neonates